Cytokines and adhesion molecules in mesothelial cell pathophysiology

Sepsis

Volumn 3, Issue 4, 1999, Pages 271-283

  Garlanda, Cecilia ^a   Mantovani, Alberto ^a  

^a Ist Ric Farmacologiche Mario Negri ^*  (Italy)

Author keywords

Adhesion molecules; Chemokines; Cytokines; Inflammation; Mesothelium

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; THROMBIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; EFFUSION; HEALING; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE MIGRATION; MESOTHELIUM CELL; PERICARDIUM; PERITONEUM; PLEURA; REVIEW; TUMOR CELL;

EID: 0033306216     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009812225580     Document Type: Review

References (137)

1. van Niekerk CC, Jap PH, Thomas CM, Ramaekers FC, Poels LG. Marker profile of mesothelial cells versus ovarian carcinoma cells. Int J Cancer 1989;43:1065-1071.
2. Wu YJ, Parker LM, Binder NE, Beckett MA, Sinard JH, Griffiths CT. The mesothelial keratins: A new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 1982;31:693-703.
3. Versnel MA, Bouts MJ, Hoogsteden HC, van der Kwast TH, Delahaye M, Hagemeijer A. Establishment of human malignant mesothelioma cell lines. Int J Cancer 1989; 44:256-260.
4. Garlanda C, Dejana E. Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 1997;17: 1193-1202.
5. Jonjic N, Peri G, Bernasconi S, Sciacca FL, Colotta F, Pelicci P, Lanfrancone L, Mantovani A. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992;176:1165-1174.
6. Connell ND, Rheinwald JG. Regulation of the cytoskeleton in mesothelial cells: Reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 1983;34:245-253.
7. van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van-Bockel J, van Muijen GN. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990;75:1490-1497.
8. Ohtsuka A, Yamana S, Murakami T. Localization of membrane-associated sialomucin on the free surface of mesothelial cells of the pleura, pericardium, and peritoneum. Histochem Cell Biol 1997;107:441-447.
9. Pelin K, Hirvonen A, Linnainmaa K. Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells. Carcinogenesis 1994;15:2673-2675.
10. Nose A, Takeichi M. A novel cadherin cell adhesion molecule: Its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol 1986;103: 2649-2658.
11. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-1455.
12. Martin Padura I, De Castellarnau C, Uccini S, Pilozzi E, Natali PG, Nicotra MR, Ughi F, Azzolini C, Dejana E, Ruco L. Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol 1995;175:51-57.
13. Kupryjanczyk J, Karpinska G. Desmin expression in reactive mesothelium: A potential aid in evaluation of gynecologic specimens. Int J Gynecol Pathol 1998;17:123-128.
14. Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci USA 1996;93: 136-140.
15. Zeillemaker AM, Verbrugh HA, Hoynck van Papendrecht AA. CA125 secretion by peritoneal mesothelial cells. J Clin Pathol 1994;47:263-265.
16. Attanoos RL, Webb R, Gibbs AR. CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma. Histopathology 1997;30:260-263.
17. Shimotsuma M, Takahashi T, Kawata M, Dux K. Cellular subsets of the milky spots in the human greater omentum. Cell Tissue Res 1991;264:599-601.
18. Wijffels JF, Hendrickx RJ, Steenbergen JJ, Eestermans ILB. Milky spots in the mouse omentum may play an important role in the origin of peritoneal macrophages. Res Immunol 1992;143:401-409.
19. Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today 1999;20:312-316.
20. Beagley KW, Murray AM, Mcghee JR, Eldridge JH. Peritoneal cavity CD5 (B1a) B cells: Cytokine induced IgA secretion and homing to intestinal lamina propria in SCID mice. Immunol Cell Biol 1995;73:425-432.
21. Antony VB, Godbey SW, Kunkel SL, Hott JW, Hartman DL, Burdick MD, Strieter RM. Recruitment of inflammatory cells to the pleural space - Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 1993;151:7216-7223.
22. Springer TA. Traffic signal for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76: 301-314.
23. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989;10:370-375.
24. Mantovani A, Bussolino F, Introna M. Cytokine regulation of endothelial cell function: From molecular level to the bed side. Immunol Today 1997;18:231-239.
25. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.
26. Duperray A, Languino LR, Plescia J, McDowall A, Hogg N, Craig AG, Altieri DC. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 1997; 272:436-441.
27. D'Souza SE, Byers-Ward VJ, Gardiner EE, Wang H, Sung SS. Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen. J Biol Chem 1996;271:24270-24277.
28. Cannistra SA, Ottensmeier C, Tidy J, Defranzo B. Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp Hematol 1994;22:996-1002.
29. Cybulsky MI, Fries JW, Williams AJ, Sultan P, Davis VM, Gimbrone MAJ, Collins T. Alternative splicing of human VCAM-1 in activated vascular endothelium. Am J Pathol 1991;138:815-820.
30. Sironi M, Sciacca FL, Matteucci C, Conni M, Vecchi A, Bernasconi S, Minty A, Caput D, Ferrara P, Colotta F, Mantovani A. Regulation of endothelial and mesothelial cell function by interleukin-13: Selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994;84:1913-1921.
31. Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67: 1033-1036.
32. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994;15:490-495.
33. Bittinger F, Klein CL, Skarke C, Brochhausen C, Rohrig O, Kohler H, Kirkpatrick CJ. PECAM-1 expression in human mesothelial cells: An in vitro study. Pathobiology 1996;64: 320-327.
34. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992;6:2591-2599.
35. Klein CL, Bittinger F, Skarke CC, Wagner M, Kohler H, Kirkpatrick CJ. Effects of cytokines on the expression of cell adhesion molecules by cultured human omental mesothelial cells. Pathobiology 1995;63:204-212.
36. Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA, Leguit P, Verbrugh HA, Roos D. Neutrophil adherence to and migration across monolayers of human peritoneal mesothelial cells. The role of mesothelium in the influx of neutrophils during peritonitis. J Lab Clin Med 1996;127: 279-286.
37. Liberek T, Topley N, Luttmann W, Williams JD. Adherence of neutrophils to human peritoneal mesothelial cells: Role of intercellular adhesion molecule-1. J Am Soc Nephrol 1996;7: 208-217.
38. Earth MW, Hendrzak JA, Melnicoff MJ, Morahan PS. Review of the macrophage disappearance reaction. [Review] [52 refs]. J Leukocyte Biol 1995;57:361-367.
39. D'Silva H, Yoshida T, Cohen S. The effect of lymphokines on macrophage accumulation and disappearance in the peritoneal cavity. J Exp Pathol 1983;1:61-69.
40. Sonozaki H, Papermaster V, Yoshida T, Cohen S. Desensitization: effects on cutaneous and peritoneal manifestations of delayed hypersensitivity in relation to lymphokine production. J Immunol 1975;115:1657-1661.
41. Sonozaki H, Cohen S. The macrophage disappearance reaction: Mediation by a soluble lymphocyte-derived factor. Cell Immunol 1971;2:341-352.
42. Sonozaki H, Cohen S. The effect of sensitized lymphocytes on peritoneal exudate macrophages in the guinea pig. J Immunol 1971;106:1404-1406.
43. Lawrence MB, Kansas GS, Kunkel EJ, Ley K. Threshold levels of fluid shear promote leukocyte adhesion through selectins (CD62L,P,E) [published erratum appears in J Cell Biol 1997 Apr 7×7(1)261]. J Cell Biol 1997;136:717-727.
44. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859-873.
45. Tsujimoto H, Takhashi T, Hagiwara A, Shimotsuma M, Osaki K, Sasaki S, Shirasu M, Sakakibara T, Ohyama T, etal. Site-specific implantation in the milky spots of malignant cells in peritoneal dissemination: Immunohistochemical observation in mice inoculated intraperitoneally with bromodeoxyuridine-labelled cells. Br J Cancer 1995;71: 468-472.
46. Cannistra SA, Kansas GS, Niloff J, Defranzo B, Kim Y, Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium invitro is partly mediated by CD44H. Cancer Res 1993;53:3830-3838.
47. Gardner MJ, Jones LM, Catterall JB, Turner GA. Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett 1995;91:229-234.
48. Nakashio T, Narita T, Akiyama S, Kasai Y, Kondo K, Ito K, Takagi H, Kannagi R. Adhesion molecules and TGF-beta1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells. Int J Cancer 1997;70:612-618.
49. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-270.
50. Malik S, Balkwill F. Epithelial ovarian cancer: A cytokine propelled disease? [Editorial]. Br J Cancer 1991;64: 617-620.
51. Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 1993;91:2194-2206.
52. Malik ST, Naylor MS, East N, Oliff A, Balkwill FR. Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur J Cancer 1990;26:1031-1034.
53. Ikubo A, Morisaki T, Katano M, Kitsuki H, Anan K, Tanaka M, Torisu M. A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol 1995;77: 27-32.
54. Yashiro M, Chung YS, Inoue T, Nishimura S, Matsuoka T, Sowa M. Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination. Int J Cancer 1996;67: 289-293.
55. Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination. Cancer 1996;77:1668-1675.
56. Nishimura S, Hirakawa-Chung KY, Yashiro M, Inoue T, Fujihara T, Murahashi K, Sawada T, Nakata B, Jikihara I, Sowa M. TGF-beta1 produced by gastric cancer cells affects mesothelial cell morphology in peritoneal dissemination. Int J Oncol 1998;12:847-851.
57. Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M. Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 1996;74:1406-1412.
58. Rieppi M, Vergani V, Gatto C, Zanetta G, Allavena P, Giavazzi R. Mesothelial cells induce the motility of human ovarian carcinoma cells. Int J Cancer 1999;80:303-307.
59. Gerwin BI. Cytokine signaling in mesothelial cells: receptor expression closes the autocrine loop. [Review] [27 refs]. Am J Resp Cell Mol Biol 1996;14:505-507.
60. Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD. Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 1989;74:940-946.
61. Lanfrancone L, Boraschi D, Ghiara P, Falini B, Grignani F, Peri G, Mantovani A, Pelicci PG. Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992;80: 2835-2842.
62. Rennick D, Yang G, Gemmell L, Lee F. Control of hemopoieses by a bone marrow stromal cell clone: lipopolysaccharide- and interleukin-1-inducible production of colony-stimulating factors. Blood 1987;69:682-691.
63. Koenen HJ, Smit MJ, Simmelink MM, Schuurman B, Beelen RH, Meijer S. Effect of intraperitoneal administration of granulocyte/macrophage-colony-stimulating factor in rats on omental milky-spot composition and tumoricidal activity in vivo and in vitro. Cancer Immunol Immunother 1996;42: 310-316.
64. Rezzani R, Rodella L, Zauli G, Caimi L, Vitale M. Mouse peritoneal cells as a reservoir of late dendritic cell progenitors. Br J Haematol 1999;104:111-118.
65. van Westreenen M, Pronk A, Diepersloot RJ, de Groot PG. Chlamydia trachomatis infection of human mesothelial cells alters proinflammatory, procoagulant, and fibrinolytic responses. Infect Immun 1998;66:2352-2355.
66. Warner SJ, Auger KR, Libby P. Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol 1987;139:1911-1917.
67. Dinarello CA, Ikejima T, Warner SJ, Orencole SF, Lonnemann G, Cannon JG, Libby P. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 1987;139:1902-1910.
68. Topley N, Jorres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, Muller C, Coles GA, Davies M, Williams JD. Human peritoneal mesothelial cells synthesize interleukin-6 - Induction by IL-1beta and TNFalpha. Kidney Int 1993;43:226-233.
69. Offner FA, Obrist P, Stadlmann S, Feichtinger H, Herold M, Zwierzina H, Hittmair A, Mikuz G, Abendstein B. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 1995;7:542-547.
70. Kinnaert P, De Wilde JP, Bournonville B, Husson C. Direct activation of human peritoneal mesothelial cells by heat-killed microorganisms. Ann Surgery 1996;224:749-754; discus.
71. Witowski J, Jorres A, Coles GA, Williams JD, Topley N. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA. Kidney Int 1996;50:1212-1223.
72. Erroi A, Sironi M, Chiaffarino F, Chen ZG, Mengozzi M, Mantovani A. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int J Cancer 1989;44:795-801.
73. Watson JM, Sensintaffar JL, Berek JS, Martinez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990;50:6959-6965.
74. Gastl G, Plante M, Finstad CL, Wong GY, Federici MG, Rubin SC. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 1993;83:433-441.
75. Chalas E, Welshinger M, Engellener W, Chumas J, Barbieri R, Mann WJ. The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 1992;166:974-977.
76. Wu S, Rodabaugh K, Martinez-Maza O, Watson JM, Silberstein DS, Boyer CMP, Weinberg JB, Berek JS, Bast RC Jr. Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha. Am J Obstet Gynecol 1992;166: 997-1007.
77. Tanner J, Tosato G. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest 1991;88:239-247.
78. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568.
79. Hedrick JA, Zlotnik A. Chemokines and lymphocyte biology. Curr Opin Immunol 1996;8:343-347.
80. Rollins BJ. Chemokines. Blood 1997;90:909-928.
81. Boylan AM, Ruegg C, Kim KJ, Hebert CA, Hoeffel JM, Pytela R, Sheppard D, Goldstein IM, Broaddus VC. Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J Clin Invest 1992;89:1257-1267.
82. Goodman RB, Wood RG, Martin TR, Hanson Painton O, Kinasewitz GT. Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8. J Immunol 1992;148:457-465.
83. Topley N, Brown Z, Jorres A, Westwick J, Davies M, Coles GA, Williams JD. Human peritoneal mesothelial cells synthesize interleukin-8 - Synergistic induction by interleukin-1-beta and tumor necrosis factor-alpha. Am J Pathol 1993;142:1876-1886.
84. Antony VB, Hott JW, Kunkel SL, Godbey SW, Burdick MD, Stricter RM. Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am J Resp Cell Mol Biol 1995;12:581-588.
85. Li FK, Davenport A, Robson RL, Loetscher P, Rothlein R, Williams JD. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-I expression. Kidney Int 1998;54:2170-2183.
86. Visser CE, Tekstra J, Brouwer-Steenbergen JJ, Tuk CW, Sampat-Sardjoepersad SC, Meijer S, Krediet RT, Beelen RH. Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin Exp Immunol 1998;112:270-275.
87. Mohammed KA, Nasreen N, Ward MJ, Mubarak KK, Rodriguez-Panadero F. Mycobacterium-mediated chemokine expression in pleural mesothelial cells: Role of C-C chemokines in tuberculous pleurisy. J Infect Dis 1998;178:1450-1456.
88. Coulomb-L'Erminé A, Amara A, Schiff C, Durand-Gasselin I, Foussat A, Delaunay T, Chaouat G, Capron F, Ledee N, Galanaud P, Arenzana-Seisdedos F, Emilie D. Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: Expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. Proc Natl Acad Sci USA 1999;96:8585-8590.
89. Antony VB, Owen CL, Hadley KJ. Pleural mesothelial cells stimulated by asbestos release chemotactic activity for neutrophils in vitro. Am Rev Respir Dis 1989;139:199-206.
90. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-5138.
91. Rot A. Endothelial cell binding of NAP-1/IL-8: Role in neutrophil emigration. Immunol Today 1992;13:291-294.
92. Galffy G, Mohammed KA, Dowling PA, Nasreen N, Ward MJ. Interleukin 8: An autocrine growth factor for malignant mesothelioma. Cancer Res 1999;59:367-371.
93. Mohammed KA, Nasreen N, Ward MJ, Antony VB. Helper T cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural mesothelial cells. Am J Resp Crit Care Med 1999;159:1653-1659.
94. Mohammed KA, Nasreen N, Ward MJ, Antony VB. Macrophage inflammatory protein-1alpha C-C chemokine in parapneumonic pleural effusions. J Lab Clin Med 1998;132: 202-209.
95. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-638.
96. Cattoretti G, Parravicini C, Bonati A, Buscaglia M, Plebani A, Delia D, Rilke F. Terminal deoxynucleotidyl transferase-positive B cell precursors in fetal lymph nodes and extra-hemopoietic tissues. Eur J Immunol 1989;19:493-500.
97. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, Grage B, Schmahl M, Knabbe C. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996;148:1679-1688.
98. Lin CY, Chen WP, Yang LY, Chen A, Huang TP. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Am J Nephrol 1998;18:513-519.
99. Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW, Harris CC. Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 1987;47:6180-6184.
100. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995;92:2572-2576.
101. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Allen R, Sidman C, Proetzel G, Calvin D, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
102. Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Gress RE, Karlsson S. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am J Pathol 1995;146:264-275.
103. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Roberts AB, Sporn MB, Ward JM, Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-774.
104. Jagirdar J, Lee TC, Reibman J, Gold LI, Aston C, Begin R, Rom WN. Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. Environ Health Persp 1997;105(Suppl)5:1197-1203.
105. Hirte HW, Clark DA, O'Connell G, Rusthoven J, Mazurka J. Reversal of suppression of lymphokine-activated killer cells by transforming growth factor-beta in ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody. Cell Immunol 1992;142:207-216.
106. Pisa P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A, Gerdin B, Kiessling R. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992;89:7708-7712.
107. Welch DR, Fabra A, Nakajima M. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 1990; 87:7678-7682.
108. Yanagihara K, Tsumuraya M. Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 1992;52:4042-4045.
109. Hurteau J, Rodriguez GC, Whitaker RS, Shah S, Mills G, Berchuck A. Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 1994;74:93-99.
110. Colotta F, Dower SK, Sims JE, Mantovani A. The type II 'decoy' receptor: Novel regulatory pathway for interleukin-1. Immunol Today 1994;15:562-566.
111. Holmdahl L. The role of fibrinolysis in adhesion formation. [Review] [44 refs]. Eur J Sur 1997;24-31.
112. Tietze L, Elbrecht A, Schauerte C, Klosterhalfen B, Amo-Takyi B, Gehlen J, Winkeltau G, Mittermayer C, Handt S. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta). Thromb Haemost 1998;79: 362-370.
113. Whawell SA, Thompson JN. Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur J Sur 1995;161:315-318.
114. Rougier JP, Guia S, Hagege J, Nguyen G, Ronco PM. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures; Transcriptional regulation by TGF-beta 1. Kidney Int 1998;54:87-98.
115. Lucas PA, Warejcka DJ, Young HE, Lee BY. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-beta1. J Surg Res 1996;65:135-138.
116. Verhagen HJ, Heijnen-Snyder GJ, Vink T, Pronk A, van-Vroonhoven TJ, Eikelboom BC, Sixma JJ, de Groot PG. Tissue factor expression on mesothelial cells is induced during in vitro culture - manipulation of culture conditions creates perspectives for mesothelial cells as a source for cell seeding procedures on vascular grafts. Thromb Haemost 1995;74:1096-1102.
117. Verhagen HJ, Heijnen-Snyder GJ, Pronk A, Vroom TM, vanVroonhoven TJ, Eikelboom BC, Sixma JJ, de Groot PG. Thrombomodulin activity on mesothelial cells: Perspectives for mesothelial cells as an alternative for endothelial cells for cell seeding on vascular grafts. Br J Haematol 1996;95: 542-549.
118. Sitter T, Haslinger B, Mandl S, Fricke H, Held E. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity. J Am Soc Nephrol 1998;9:2005-2012.
119. Topley N, Petersen MM, Mackenzie R, Neubauer A, Kaever V, Davies M, Coles GA, Jorres A, Williams JD. Human peritoneal mesothelial cell prostaglandin synthesis: Induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 1994;46:900-909.
120. Hott JW, Godbey SW, Antony VB. Mesothelial cell modulation of pleural repair: Thrombin stimulated mesothelial cells release prostaglandin E2. Prostag Leukotr Ess 1994;51: 329-335.
121. Nathan C, Xie QW. Nitric oxide synthases: Roles, tolls, and controls. Cell 1994;78:915-918.
122. Choe N, Tanaka S, Kagan E. Asbestos fibers and interleukin-1 upregulate the formation of reactive nitrogen species in rat pleural mesothelial cells. Am J Resp Cell Mol Biol 1998;19:226-236.
123. Owens MW, Grisham MB. Nitric oxide synthesis by rat pleural mesothelial cells: Induction by cytokines and lipopolysaccharide. Am J Physiol 1993;265:L110-L116.
124. Choe N, Tanaka S, Xia W, Hemenway DR, Roggli VL, Kagan E. Pleural macrophage recruitment and activation in asbestos-induced pleural injury. Environ Health Persp 1997;105(Suppl)5:1257-1260.
125. Owens MW, Milligan SA, Grisham MB. Inhibition of rat pleural mesothelial cell nitric oxide synthesis by transforming growth factor-beta 1. Inflammation 1996;20:637-646.
126. Tanaka S, Choe N, Hemenway DR, Zhu S, Matalon S, Kagan E. Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat. J Clin Invest 1998;102:445-454.
127. Owens MW, Milligan SA, Grisham MB. Nitric oxide-dependent N-nitrosating activity of rat pleural mesothelial cells. Free Radical Res 1995;23:371-378.
128. Buard A, Vivo C, Monnet I, Boutin C, Pilatte Y, Jaurand MC. Human malignant mesothelioma cell growth: Activation of janus kinase 2 and signal transducer and activator of transcription 1 alpha for inhibition by interferon-gamma. Cancer Res 1998;58:840-847.
129. Boutin C, Nussbaum E, Monnet I, Bignon J, Vanderschueren R, Guerin JC, Menard O, Mignot P, Dabouis G, Douillard JY. Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer 1994;74:2460-2467.
130. Mutti L, Valle MT, Balbi B, Orengo AM, Lazzaro A, Alciato P, Gatti E, Pozzi E. Primary human mesothelioma cells express class II MHC, ICAM-1 and B7-2 and can present recall antigens to autologous blood lymphocytes. Int J Cancer 1998;78:740-749.
131. Owens MW, Milligan SA. Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived factor. Inflammation 1994;18:77-87.
132. Owens MW, Grimes SR. Pleural mesothelial cell response to inflammation: Tumor necrosis factor-induced mitogenesis and collagen synthesis. Am J Physiol 1993;265:L382-L388.
133. Van der Meeren A, Seddon MB, Betsholtz CA, Lechner JF. Tumorigenic conversion of human mesothelial cells as a consequence of platelet-derived growth factor-A chain overexpression. Amer J Respir Cell Molec Biol 1993;8:214-221.
134. Bird SD, Hasan Q, Davis PF, Walker RJ. Platelet derived growth factor-BB induced calcium transients in cultured human peritoneal mesothelial cells. ASAIO J 1998;44:835-840.
135. Versnel MA, Claesson Welsh L, Hammacher A, Bouts MJ, van der Kwast TH, Eriksson A, Willemsen R, Weima SM, Hoogsteden HC, Hagemeijer A, Heldin C-H. Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors. Oncogene 1991;6:2005-2011.
136. Mutsaers SE, McAnulty RJ, Laurent GJ, Versnel MA, Papadimitriou JM. Cytokine regulation of mesothelial cell proliferation in vitro and in vivo. Eur J Cell Biol 1997;72:24-29.
137. Hott JW, Sparks JA, Godbey SW, Antony VB. Mesothelial cell response to pleural injury: Thrombin-induced proliferation and chemotaxis of rat pleural mesothelial cells. Am J Resp Cell Mol Biol 1992;6:421-425.